POTENZA, ALESSIA
POTENZA, ALESSIA
DIPARTIMENTO DI MEDICINA E CHIRURGIA (SCHOOL OF MEDICINE AND SURGERY)
Correction to: Type I IFNs promote cancer cell stemness by triggering the epigenetic regulator KDM1B (Nature Immunology, (2022), 23, 9, (1379-1392), 10.1038/s41590-022-01290-3)
2024 Musella, M; Guarracino, A; Manduca, N; Galassi, C; Ruggiero, E; Potenza, A; Maccafeo, E; Manic, G; Mattiello, L; Soliman Abdel Rehim, S; Signore, M; Pietrosanto, M; Helmer-Citterich, M; Pallocca, M; Fanciulli, M; Bruno, T; De Nicola, F; Corleone, G; Di Benedetto, A; Ercolani, C; Pescarmona, E; Pizzuti, L; Guidi, F; Sperati, F; Vitale, S; Macchia, D; Spada, M; Schiavoni, G; Mattei, F; De Ninno, A; Businaro, L; Lucarini, V; Bracci, L; Arico, E; Ziccheddu, G; Facchiano, F; Rossi, S; Sanchez, M; Boe, A; Biffoni, M; De Maria, R; Vitale, I; Sistigu, A
Harnessing the tumor microenvironment to boost adoptive T cell therapy with engineered lymphocytes for solid tumors
2024 Spiga, M; Martini, E; Maffia, M; Ciceri, F; Ruggiero, E; Potenza, A; Bonini, C
TIM-3, LAG-3, or 2B4 gene disruptions increase the anti-tumor response of engineered T cells
2024 Cianciotti, B; Magnani, Z; Ugolini, A; Camisa, B; Merelli, I; Vavassori, V; Potenza, A; Imparato, A; Manfredi, F; Abbati, D; Perani, L; Spinelli, A; Shifrut, E; Ciceri, F; Vago, L; Di Micco, R; Naldini, L; Genovese, P; Ruggiero, E; Bonini, C
Epithelial ovarian cancer is infiltrated by activated effector T cells co-expressing CD39, PD-1, TIM-3, CD137 and interacting with cancer cells and myeloid cells
2023 Tassi, E; Bergamini, A; Wignall, J; Sant'Angelo, M; Brunetto, E; Balestrieri, C; Redegalli, M; Potenza, A; Abbati, D; Manfredi, F; Cangi, M; Magliacane, G; Scalisi, F; Ruggiero, E; Maffia, M; Trippitelli, F; Rabaiotti, E; Cioffi, R; Bocciolone, L; Candotti, G; Candiani, M; Taccagni, G; Schultes, B; Doglioni, C; Mangili, G; Bonini, C
Harnessing T cell exhaustion and trogocytosis to isolate patient-derived tumor-specific TCR
2023 Manfredi, F; Stasi, L; Buonanno, S; Marzuttini, F; Noviello, M; Mastaglio, S; Abbati, D; Potenza, A; Balestrieri, C; Cianciotti, B; Tassi, E; Feola, S; Toffalori, C; Punta, M; Magnani, Z; Camisa, B; Tiziano, E; Lupo-Stanghellini, M; Branca, R; Lehtio, J; Sikanen, T; Haapala, M; Cerullo, V; Casucci, M; Vago, L; Ciceri, F; Bonini, C; Ruggiero, E
Revealing and harnessing CD39 for the treatment of colorectal cancer and liver metastases by engineered T cells
2023 Potenza, A; Balestrieri, C; Spiga, M; Albarello, L; Pedica, F; Manfredi, F; Cianciotti, B; De Lalla, C; Botrugno, O; Faccani, C; Stasi, L; Tassi, E; Bonfiglio, S; Scotti, G; Redegalli, M; Biancolini, D; Camisa, B; Tiziano, E; Sirini, C; Casucci, M; Iozzi, C; Abbati, D; Simeoni, F; Lazarevic, D; Elmore, U; Fiorentini, G; Lullo, G; Casorati, G; Doglioni, C; Tonon, G; Dellabona, P; Rosati, R; Aldrighetti, L; Ruggiero, E; Bonini, C
CRISPR-based gene disruption and integration of high-avidity, WT1-specific T cell receptors improve antitumor T cell function
2022 Ruggiero, E; Carnevale, E; Prodeus, A; Magnani, Z; Camisa, B; Merelli, I; Politano, C; Stasi, L; Potenza, A; Cianciotti, B; Manfredi, F; Di Bono, M; Vago, L; Tassara, M; Mastaglio, S; Ponzoni, M; Sanvito, F; Liu, D; Balwani, I; Galli, R; Genua, M; Ostuni, R; Doglio, M; O'Connell, D; Dutta, I; Yazinski, S; Mckee, M; Arredouani, M; Schultes, B; Ciceri, F; Bonini, C
Type I IFNs promote cancer cell stemness by triggering the epigenetic regulator KDM1B
2022 Musella, M; Guarracino, A; Manduca, N; Galassi, C; Ruggiero, E; Potenza, A; Maccafeo, E; Manic, G; Mattiello, L; Soliman Abdel Rehim, S; Signore, M; Pietrosanto, M; Helmer-Citterich, M; Pallocca, M; Fanciulli, M; Bruno, T; De Nicola, F; Corleone, G; Di Benedetto, A; Ercolani, C; Pescarmona, E; Pizzuti, L; Guidi, F; Sperati, F; Vitale, S; Macchia, D; Spada, M; Schiavoni, G; Mattei, F; De Ninno, A; Businaro, L; Lucarini, V; Bracci, L; Arico, E; Ziccheddu, G; Facchiano, F; Rossi, S; Sanchez, M; Boe, A; Biffoni, M; De Maria, R; Vitale, I; Sistigu, A
Workflow for high-dimensional flow cytometry analysis of T cells from tumor metastases
2022 Faccani, C; Rotta, G; Clemente, F; Fedeli, M; Abbati, D; Manfredi, F; Potenza, A; Anselmo, A; Pedica, F; Fiorentini, G; Villa, C; Protti, M; Doglioni, C; Aldrighetti, L; Bonini, C; Casorati, G; Dellabona, P; de Lalla, C
Effector T cells co-expressing PD1 and CD39 are enriched in colorectal tumors: implications for cancer immunotherapy
2021 Potenza, A
Flow cytometry data mining by cytoChain identifies determinants of exhaustion and stemness in TCR-engineered T cells
2021 Manfredi, F; Abbati, D; Cianciotti, B; Stasi, L; Potenza, A; Ruggiero, E; Magnani, Z; Carnevale, E; Doglio, M; Noviello, M; Tassi, E; Balestrieri, C; Buonanno, S; Clemente, F; De Lalla, C; Protti, M; Mondino, A; Casorati, G; Dellabona, P; Bonini, C
TCR Redirected T Cells for Cancer Treatment: Achievements, Hurdles, and Goals
2020 Manfredi, F; Cianciotti, B; Potenza, A; Tassi, E; Noviello, M; Biondi, A; Ciceri, F; Bonini, C; Ruggiero, E